LUNGPulmonx Corp

Nasdaq pulmonx.com


$ 7.31 $ 0.00 (0 %)    

Friday, 30-Aug-2024 15:59:55 EDT
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 7.32
$ 7.30 x 100
$ 7.32 x 206
-- - --
$ 5.46 - $ 14.84
111,789
na
286.6M
$ 1.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-02-2024 06-30-2024 10-Q
2 05-03-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-pulmonx-lowers-price-target-to-12

Piper Sandler analyst Jason Bednar maintains Pulmonx (NASDAQ: LUNG) with a Overweight and lowers the price target from $14 t...

 canaccord-genuity-maintains-buy-on-pulmonx-raises-price-target-to-16

Canaccord Genuity analyst Jon Young maintains Pulmonx (NASDAQ:LUNG) with a Buy and raises the price target from $15 to $16.

 wells-fargo-maintains-equal-weight-on-pulmonx-lowers-price-target-to-10

Wells Fargo analyst Larry Biegelsen maintains Pulmonx (NASDAQ:LUNG) with a Equal-Weight and lowers the price target from $14...

 pulmonx-q2-2024-gaap-eps-039-beats-044-estimate-sales-20783m-beat-20134m-estimate

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.44) by 11...

 lake-street-initiates-coverage-on-pulmonx-with-buy-rating-announces-price-target-of-12

Lake Street analyst Frank Takkinen initiates coverage on Pulmonx (NASDAQ:LUNG) with a Buy rating and announces Price Target ...

 canaccord-genuity-maintains-buy-on-pulmonx-lowers-price-target-to-15

Canaccord Genuity analyst Jon Young maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $16 to $15.

Core News & Articles
Market-Moving News May 2nd
05/02/2024 12:39:37

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical...

 pulmonx-q1-2024-gaap-eps-036-beats-046-estimate-sales-18854m-beat-17893m-estimate

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.46) by 21...

 piper-sandler-reiterates-overweight-on-pulmonx-maintains-17-price-target

Piper Sandler analyst Jason Bednar reiterates Pulmonx (NASDAQ:LUNG) with a Overweight and maintains $17 price target.

 pulmonx-announces-appointment-of-mehul-joshi-as-chief-financial-officer-effective-april-3-2024

Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatment...

 pulmonx-announces-treatment-of-the-first-patient-with-the-aeriseal-system-in-convert-ii-pivotal-trial

AeriSeal System Shows Promise in Limiting Collateral Ventilation, Potentially Enabling a Greater Number of Severe COPD/Emphysem...

 analyst-ratings-for-pulmonx
Analyst Ratings For Pulmonx
02/23/2024 12:00:55

 why-etsy-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Etsy, Inc.

 pulmonx-q4-2023-gaap-eps-036-beats-042-estimate-sales-1928m-beat-1827m-estimate

Pulmonx (NASDAQ:LUNG) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.42) by 14...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION